Review of a Sotalol IV Retrospective Study Presented at ACC.24
Video interview with Keturah DelGrosso, PharmD, BCPS
Description
Continuing our conversation with Dr. Keturah DelGrosso (née Weaver), we explore a retrospective study presented at ACC.24 comparing the real-world effectiveness and safety of intravenous to oral sotalol loading.
About Dr. Keturah DelGrosso:
Dr. DelGrosso currently serves as the Director of Geisinger’s PGY1 Pharmacy Residency Program, as well as being a clinical pharmacist in cardiology in Geisinger’s Medication Therapy Disease Management program.
Dr. DelGrosso is a graduate of Lake Erie College of Osteopathic Medicine School of Pharmacy. She completed her pre-pharmacy studies at the University of Pittsburgh and went on to earn her Doctor of Pharmacy degree in 2018. After graduation, she completed a PGY1 pharmacy practice residency at Conemaugh Memorial Medical Center in Johnstown, Pennsylvania.
Her professional interests include preventive medicine, diabetes, hypertension, heart failure, dyslipidemia, smoking cessation, teaching and transitions of care.
Dr. DelGrosso’s appearance in this video was sponsored by AltaThera.
References
- Sotalol IV [package insert]. Chicago, IL: AltaThera Pharmaceuticals; 2023. sotaloliv.com/pi
- BetaPace [package insert]. Zug, Switzerland: Covis Pharma; 2023.
- Somberg JC, Vinks AA, Dong M, Molnar J. Model-Informed Development of Sotalol Loading and Dose Escalation
Employing an Intravenous Infusion. Cardiol Res. 2020;11(5):294-304. doi:10.14740/cr1143 - Weaver, K, Heikkinen, B, Novak, M. REAL-WORLD COMPARATIVE EFFECTIVENESS AND SAFETY OF INTRAVENOUS TO ORAL SOTALOL LOADING AMONG PATIENTS WITH ATRIAL ARRHYTHMIAS. J Am Coll Cardiol. 2024 Apr, 83 (13_Supplement) 8. doi:10.1016/S0735-1097(24)01998-3